Impact of Gender on Molecular AML Subclasses - a Harmony Alliance Study
Tommaso Matteuzzi(Leukemia and Lymphoma Society), Lars Bullinger(Stanford University), Pau Montesinos(Instituto de Salud Carlos III), Christian Thiede(University Hospital Carl Gustav Carus), María Abáigar(Universidad de Salamanca), Michel van Speybroeck(Janssen (Belgium)), Alberto Hernández‐Sánchez, Eric Sträng(Humboldt-Universität zu Berlin), Jorge Sierra(Universitat Autònoma de Barcelona), Klaus H. Metzeler(University Hospital Leipzig), Javier Martínez Elicegui(Instituto de Investigación Biomédica de Salamanca), Frederico Calado(Novartis (Switzerland)), Jurjen Versluis(Erasmus MC), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Axel Benner(Memorial Sloan Kettering Cancer Center), Castellani Gastone(Istituto Nazionale di Fisica Nucleare, Sezione di Bologna), Laura Jamilis(GMV Innovating Solutions (Spain)), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Jesús María Hernández‐Rivas(Universidad de Salamanca), Marta Sobas, Claude Preudomme, Daniele Dall’Olio(University of Bologna), Torsten Haferlach(Martin Luther Christian University), Renate Schulze‐Rath(Sanofi (France)), Guillermo Sanz(Instituto de Salud Carlos III), Alessandra Merlotti(University of Bologna), Michael Heuser(Martin Luther University Halle-Wittenberg), Konstanze Döhner(University Hospital Ulm), Amin T. Turki(University Hospitals of the Ruhr-University of Bochum), Jiřı́ Mayer(Masaryk University), Caroline A. Heckman(University of Helsinki), Maria Teresa Voso(University of Rome Tor Vergata), Rubén Villoria Medina(GMV Innovating Solutions (Spain)), Raúl Azibeiro Melchor(Universidad de Salamanca), Peter J.M. Valk(Erasmus MC Cancer Institute), Maral Saadati(Boehringer Ingelheim (Germany)), Ken Mills(Johns Hopkins University), Dirk Reinhardt(Society of Paediatric Oncology and Haematology), Rosa Ayala(Hospital Universitario 12 De Octubre), Sergio Amadori(Polyclinic Medical Center), Verena I. Gaidzik(European Bioinformatics Institute), Julia Krzykalla(German Cancer Research Center), Hartmut Döhner(University Hospital Ulm), Frederick Damm(Charité - Universitätsmedizin Berlin), Hervé Dombret(University of London Institute in Paris), Gert J. Ossenkoppele(Dutch Cancer Society), Ana Heredia Casanoves(GMV Innovating Solutions (Spain))
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k